Definium Therapeutics, Inc. (DFTX)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesCA24477V1058
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Definium Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:11. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Mar 2027 16:00 | -0.49 | — | — | Upcoming |
| 09 Nov 2026 16:00 | -0.56 | -0.37 | +34.0% | Beat |
| 06 Aug 2026 16:00 | -0.55 | -1.44 | -162.3% | Miss |
| 07 May 2026 16:00 | -0.49 | -0.71 | -44.0% | Miss |
| 26 Feb 2026 16:00 | -0.49 | -0.50 | -2.0% | Miss |
| 06 Nov 2025 16:00 | -0.50 | -0.78 | -54.8% | Miss |
| 31 Jul 2025 16:00 | -0.36 | -0.50 | -38.3% | Miss |
| 08 May 2025 07:00 | -0.37 | -0.35 | +4.3% | Beat |
| 06 Mar 2025 07:00 | -0.28 | -0.41 | -47.2% | Miss |
| 07 Nov 2024 16:00 | -0.26 | -0.18 | +31.6% | Beat |
| 13 Aug 2024 07:00 | -0.33 | -0.29 | +13.0% | Beat |
| 08 May 2024 16:00 | -0.56 | -1.14 | -102.9% | Miss |
| 28 Feb 2024 07:00 | -0.48 | -0.59 | -23.6% | Miss |
| 02 Nov 2023 16:00 | -0.67 | -0.45 | +32.5% | Beat |
| 03 Aug 2023 16:00 | -0.53 | -0.76 | -44.1% | Miss |
| 04 May 2023 16:00 | -0.44 | -0.65 | -48.9% | Miss |
| 09 Mar 2023 16:00 | -0.54 | -0.27 | +49.1% | Beat |
| 10 Nov 2022 08:00 | -0.63 | -0.56 | +11.1% | Beat |
| 11 Aug 2022 16:00 | -0.75 | -0.60 | +20.0% | Beat |
| 16 May 2022 08:00 | -0.70 | -0.60 | +14.3% | Beat |
| 28 Mar 2022 08:00 | -0.67 | -0.75 | -11.1% | Miss |
| 12 Nov 2021 09:00 | -0.55 | -0.90 | -63.6% | Miss |
| 12 Aug 2021 17:00 | -0.60 | -1.35 | -125.0% | Miss |
| 12 Nov 2020 19:00 | -0.45 | -0.45 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -183.8M | — | -2.06 | -33.8% | -131.6M |
| 2024 | 0 | — | -108.7M | — | -1.54 | +36.9% | -79.1M |
| 2023 | 0 | — | -95.7M | — | -2.44 | -32.6% | -64.4M |
| 2022 | 0 | — | -56.8M | — | -1.84 | — | -50.1M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 33.84 | 35.97 | 32.75 | 33.00 | -0.81% | 5,323,288 | |
| 02 Nov 2026 – 06 Nov 2026 | 36.51 | 36.84 | 30.17 | 33.27 | -8.42% | 9,975,900 | |
| 26 Oct 2026 – 30 Oct 2026 | 35.60 | 39.14 | 34.74 | 36.33 | +1.85% | 6,502,700 | |
| 19 Oct 2026 – 23 Oct 2026 | 32.28 | 36.34 | 32.23 | 35.67 | +11.12% | 10,235,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 36.27 | 36.30 | 32.02 | 32.10 | -13.01% | 9,350,700 | |
| 05 Oct 2026 – 09 Oct 2026 | 37.50 | 38.04 | 32.84 | 36.90 | -1.34% | 11,923,500 | |
| 28 Sep 2026 – 02 Oct 2026 | 35.92 | 39.10 | 35.51 | 37.40 | +3.40% | 11,061,600 | |
| 21 Sep 2026 – 25 Sep 2026 | 39.00 | 40.39 | 35.89 | 36.17 | -6.80% | 11,493,800 | |
| 14 Sep 2026 – 18 Sep 2026 | 43.53 | 43.77 | 36.70 | 38.81 | -0.21% | 18,822,200 | |
| 08 Sep 2026 – 11 Sep 2026 | 38.00 | 39.37 | 37.17 | 38.89 | +2.10% | 5,937,100 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Is Definium Therapeutics (DFTX) Fully Priced After Positive Phase 3 Results? (opens in a new tab) Simply Wall St. · 12 Nov 2026 08:09
- How Investors May Respond To Definium Therapeutics Stock After Phase 3 Success (opens in a new tab) Simply Wall St. · 12 Nov 2026 01:17
- Definium Therapeutics (DFTX) Following DT120 Phase 3 Data Is The Undervalued Story Intact (opens in a new tab) Simply Wall St. · 11 Nov 2026 21:10
- Definium Therapeutics Eyes FDA Filing for LSD Treatment After Three Positive Phase 3 Studies (opens in a new tab) MarketBeat · 11 Nov 2026 10:12
- Definium Q3 Earnings: Psychedelics Approval Beckons But Valuation Seems Inflated (opens in a new tab) SeekingAlpha · 10 Nov 2026 13:34
- RBC Capital Maintains Outperform on Definium Therapeutics, Raises Price Target to $70 (opens in a new tab) Benzinga · 10 Nov 2026 11:59
- Definium Therapeutics Inc (DFTX) (Q3 2026) Earnings Call Highlights: $1. ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 05:11
- Definium Therapeutics, Inc. (DFTX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 04:01
- Definium (DFTX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 02:00
- What Definium Therapeutics (DFTX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 10 Nov 2026 01:14
- Definium Therapeutics (NASDAQ:DFTX) Q3 Loss Narrower as Pipeline Momentum Builds (opens in a new tab) ChartMill · 10 Nov 2026 00:39
- Definium Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights (opens in a new tab) 09 Nov 2026 21:01
- Definium Therapeutics Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 09 Nov 2026 18:39
- Definium Therapeutics Announces New Employee Inducement Grants (opens in a new tab) 09 Nov 2026 12:01
- Definium Therapeutics (DFTX) Stock May Trade Above Fair Value On Book Value (opens in a new tab) Simply Wall St. · 19 Oct 2026 23:15
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 34.47 USD
- Market cap
- 4.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow DFTX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.